# myFibroScan vs CLDF ACE 2.0

The clearest difference is rating: CLDF ACE 2.0 at 5.0 against myFibroScan's 3.0. CLDF ACE 2.0 also leads on update cadence (every 6 days vs every 8 months) and monetization model (free vs ad-supported). myFibroScan's advantage is ratings volume (4 vs 1). On price, ads, in-app purchases and device support there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

CLDF ACE 2.0 holds the better App Store score, 5.0 against 3.0. Both are backed by a comparable volume of ratings — 4 and 1 respectively.

myFibroScan ships an update every 8 months, CLDF ACE 2.0 every 6 days. The most recent releases landed on October 26, 2026 and October 28, 2026 respectively.

## The numbers

| Metric | myFibroScan | CLDF ACE 2.0 |
| --- | --- | --- |
| Price | Free | Free |
| Rating | [3.0 (4 ratings)](https://appshunter.io/ios/app/myfibroscan/id1220487590/reviews) | **[5.0 (1 ratings)](https://appshunter.io/ios/app/cldf-ace-20/id6755418046/reviews)** |
| Number of ratings | **4** | 1 |
| Positive reviews | 0.0% of reviews | — |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | Every 8 months | **Every 6 days** |
| Monetization | Ad-supported | **Free** |
| Size | 40 MB | 37 MB |
| Requires iOS | 15.6 | **13.0** |
| Devices | **iPhone, iPad, iPod** | iPhone, iPod |
| Age rating | 17+ | 17+ |
| Developer | [ECHOSENS](https://appshunter.io/developer/977627230) | [Tactical Advantage Group LLC](https://appshunter.io/developer/1766897304) |

## What reviewers say

### myFibroScan

[App page](https://appshunter.io/ios/app/myfibroscan/id1220487590)

This app assists healthcare professionals in interpreting FibroScan® results for liver health management. It provides tools and scores based on clinical studies to aid in assessing liver disease and identifying at-risk patients.

**Highlights:** Interpretation Guide for FibroScan® results, FibroScan® based scores for liver disease assessment, Fast score for MASH patient risk identification, Agile 3+ score for advanced fibrosis identification, Agile 4 score for cirrhosis identification, MASH Treatment Eligibility Tool

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


### CLDF ACE 2.0

[App page](https://appshunter.io/ios/app/cldf-ace-20/id6755418046)

This educational app provides healthcare professionals with expert opinions, research, and management algorithms for liver diseases. It serves as a platform for tailored medical education and resources in the field of liver and gastroenterology.

**Highlights:** Expert opinions on liver disease, Clinical research summaries, Management algorithms, AI in liver disease, Digital educational content, Gastroenterology resources

**Features:** macOS Compatibility

**In-app purchases:** none


## Frequently asked questions

### Is myFibroScan free?

myFibroScan is free to download, with no in-app purchases.

### Is CLDF ACE 2.0 free?

CLDF ACE 2.0 is free to download, with no in-app purchases.

### Which has better reviews, myFibroScan or CLDF ACE 2.0?

CLDF ACE 2.0 is rated higher. myFibroScan averages 3.0 out of 5 from 4 ratings, while CLDF ACE 2.0 averages 5.0 from 1 ratings.

### Do myFibroScan or CLDF ACE 2.0 have ads?

Neither myFibroScan nor CLDF ACE 2.0 shows ads.

### Which is updated more often, myFibroScan or CLDF ACE 2.0?

myFibroScan ships an update every 8 months, and CLDF ACE 2.0 every 6 days. Most recently, myFibroScan was updated on October 26, 2026 and CLDF ACE 2.0 on October 28, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*